loadpatents
name:-0.014792919158936
name:-0.012709140777588
name:-0.00040006637573242
Tormakangas; Olli Patent Filings

Tormakangas; Olli

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tormakangas; Olli.The latest application filed is for "androgen receptor modulating compounds".

Company Profile
0.16.14
  • Tormakangas; Olli - Turku FI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Androgen receptor modulating compounds
Grant 11,046,713 - Wohlfahrt , et al. June 29, 2
2021-06-29
Carboxamide derivative and its diastereomers in stable crystalline form
Grant 10,835,515 - Tormakangas , et al. November 17, 2
2020-11-17
Androgen Receptor Modulating Compounds
App 20200299307 - WOHLFAHRT; Gerd ;   et al.
2020-09-24
Androgen receptor modulating compounds
Grant 10,711,013 - Wohlfahrt , et al.
2020-07-14
Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
App 20190321333 - TORMAKANGAS; Olli ;   et al.
2019-10-24
Carboxamide derivative and its diastereomers in stable crystalline form
Grant 10,383,853 - Tormakangas , et al. A
2019-08-20
Carboxamide derivative and its diastereomers in stable crystalline form
Grant 10,376,494 - Tormakangas , et al. A
2019-08-13
Androgen Receptor Modulating Compounds
App 20190100536 - WOHLFAHRT; Gerd ;   et al.
2019-04-04
Androgen receptor modulating compounds
Grant 10,118,933 - Wohlfahrt , et al. November 6, 2
2018-11-06
Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
App 20180280354 - TORMAKANGAS; Olli ;   et al.
2018-10-04
Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
App 20180280355 - TORMAKANGAS; Olli ;   et al.
2018-10-04
Carboxamide derivative and its diastereomers in stable crystalline form
Grant 10,010,530 - Tormakangas , et al. July 3, 2
2018-07-03
A Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
App 20180008577 - TORMAKANGAS; Olli ;   et al.
2018-01-11
Androgen Receptor Modulating Compounds
App 20170260206 - WOHLFAHRT; Gerd ;   et al.
2017-09-14
Androgen receptor modulating compounds
Grant 9,657,003 - Wohlfahrt , et al. May 23, 2
2017-05-23
Pharmacologically Active Quinazolinedione Derivatives
App 20170137387 - PRUSIS; Peteris ;   et al.
2017-05-18
Androgen Receptor Modulating Compounds
App 20150203479 - WOHLFAHRT; Gerd ;   et al.
2015-07-23
Androgen receptor modulating compounds
Grant 8,975,254 - Wohlfahrt , et al. March 10, 2
2015-03-10
Androgen receptor modulating carboxamides
Grant 8,921,378 - Tormakangas , et al. December 30, 2
2014-12-30
Androgen Receptor Modulating Carboxamides
App 20140094474 - Tormakangas; Olli ;   et al.
2014-04-03
Selective androgen receptor modulators
Grant 8,501,814 - Ratilainen , et al. August 6, 2
2013-08-06
Androgen Receptor Modulating Compounds
App 20120225867 - Wohlfahrt; Gerd ;   et al.
2012-09-06
Selective Androgen Receptor Modulators
App 20090054525 - Ratilainen; Jari ;   et al.
2009-02-26
Compounds, which are potent inhibitors of Na.sup.+ /Ca.sup.2+ exchange mechanism and are useful in the treatment of arrhythmias
Grant 7,425,568 - Koskelainen , et al. September 16, 2
2008-09-16
Propionamide derivatives useful as androgen receptor modulators
Grant 7,390,923 - Ratilainen , et al. June 24, 2
2008-06-24
Compounds, which are potent inhibitors of na+ / ca2+ exchange mechanism and are useful in the treatment of arrhythmias
App 20040235905 - Koskelainen, Tuula ;   et al.
2004-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed